General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0SBKQZ
ADC Name
TUB-040
Synonyms
TUB 040; TUB-040; TUB040
   Click to Show/Hide
Organization
Tubulis GmbH
Drug Status
Phase 1/2
Indication
In total 2 Indication(s)
Lung cancer
Phase 2
Clinical Trial
Ovarian cancer
Phase 2
Clinical Trial
Drug-to-Antibody Ratio
8
Antibody Name
A humanized, Fc-silenced IgG1 antibody targeting Napi2b
 Antibody Info 
Antigen Name
Sodium-dependent phosphate transport protein 2B (SLC34A2)
 Antigen Info 
Payload Name
Exatecan
 Payload Info 
Therapeutic Target
DNA topoisomerase 1 (TOP1)
 Target Info 
Conjugate Type
Random Cysteines
Combination Type
tubutecan